Moreover, tumor samples collected from the LINC01503 knockdown group had fewer Ki67-positive cells, whereas the miR-342-3p inhibitor had more Ki67-positive cells in contrast to the LINC01503 group (Fig. 7d). This evidence concerns the gene MKI67 and neoplasm.